{
    "title": "Sanofi, GSK to seek approval for COVID vaccine candidate",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10542507/Sanofi-GSK-seek-COVID-19-vaccine-candidate-approval.html",
    "date": "2022-02-23",
    "keywords": [
        "vaccine",
        "sanofi",
        "shot",
        "booster",
        "trial",
        "technology",
        "covid19",
        "efficacy",
        "paris",
        "approval",
        "standalone",
        "twodose",
        "year",
        "race",
        "mrna",
        "pfizerbiontech",
        "role",
        "period",
        "president",
        "gsk",
        "drugmaker",
        "partner",
        "glaxosmithkline",
        "wednesday",
        "comeback",
        "maker",
        "candidate",
        "approach",
        "influenza",
        "substance",
        "effectiveness",
        "analysis",
        "data",
        "hospitalisation",
        "disease",
        "phase",
        "study",
        "concern",
        "omicron",
        "triomphe",
        "executive",
        "vice",
        "food",
        "drug",
        "administration",
        "agency",
        "head",
        "coalition",
        "preparedness",
        "richard",
        "hatchett",
        "workforce",
        "future",
        "cepi",
        "covax",
        "facility",
        "december",
        "dominance",
        "moderna",
        "reporting",
        "sudip",
        "kargupta",
        "van",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "jason",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}